Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen UK private clinics and pharmacies advertise Mounjaro bundle prices, the monthly figure rarely tells the whole story. Bundle pricing for tirzepatide in the UK varies widely by dose and provider, and the gap between a headline number and your real out-of-pocket cost often comes down to what each bundle quietly leaves out. Mounjaro is a prescription-only medicine, so any legitimate route to it requires clinical assessment by a qualified prescriber before a pen reaches you — that clinical layer has a cost, even when it isn't listed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A 'bundle' in the UK private market usually means a multi-pen or multi-month supply of tirzepatide sold at a single quoted figure. Because Mounjaro comes in six strengths (from the 2.5 mg starting dose up to 15 mg) the price you see is almost always dose-specific. A bundle for 2.5 mg pens will sit at a different level to one for 10 mg or 15 mg pens, and the range of Mounjaro prices across doses is substantial.
Since Eli Lilly raised its UK list price from 1 September 2025, the list price of a single higher-dose pen reportedly rose from around £122 to around £330. Private providers price above or around list depending on their cost base. Those figures are the market's floor and ceiling, your actual private price sits somewhere within them, hedged by which dose, which provider, and what's bundled in. If you want a clear picture of what different configurations actually cost, the breakdown of Mounjaro bundles UK price options is worth reviewing before you commit.
The NICE appraisal of tirzepatide (TA1026) sets out the clinical thresholds for NHS access, but most adults pursuing private treatment do so precisely because NHS criteria are strict and phased, an overview of Mounjaro's UK licensing explains both routes clearly. Private pricing exists in a different lane to NHS pricing; the two are not directly comparable.
This is where the real comparison happens. A headline monthly Mounjaro bundle price UK figure can look competitive until you add the pieces that some providers charge separately. The most common extras: an initial consultation fee (sometimes £30–£75), a prescription fee on top of the medicine cost, a delivery charge per order, and aftercare or dose-review fees when you want to move to a higher strength.
Dose titration matters here. Tirzepatide treatment starts at 2.5 mg (a tolerability dose designed to settle your system before any therapeutic effect builds) and your prescriber typically increases the dose every four weeks. If each dose increase requires a paid clinical review, or if the bundle price only covers one strength, the cost of progressing through the schedule adds up fast. A quoted 5 mg Mounjaro price, for instance, tells you nothing about what it costs to get there or to move beyond it.
Delivery is another one. Some providers charge £8–£15 per order; on a monthly cadence that's quietly significant over a year of treatment. Worth asking explicitly before signing up.
At nume, one price covers the consultation, the prescription, the medicine, and next-working-day DPD delivery, tracked to your door in a plain box that gives nothing away. There are no subscription locks and no auto-renewals; every repeat order is re-reviewed by a prescriber before dispatch. We're not positioned as the cheapest option on the market, and that's a deliberate choice rather than an oversight. Our pharmacy is GPhC-registered (premises number 9012878, verifiable at the GPhC register) and every consultation is reviewed by a named clinician, not by an algorithm.
If you want to see how cheapest-bundle claims stack up once you add the hidden fees, the arithmetic usually narrows the gap considerably. Transparent all-in pricing has a different feel to a low opener and a longer checkout page. Current treatment pricing at nume is shown on the treatment page.
Mounjaro is a Prescription-Only Medicine regulated by the MHRA. Sellers offering tirzepatide at prices substantially below the market range (or through social media channels, with no clinical assessment) are a documented safety risk. The MHRA has warned publicly about counterfeit weight-loss pens, and enforcement in 2025 included seizure of roughly 20 million doses of illegally traded weight-loss medicines (around £45 million street value) and a raid on a site manufacturing fake tirzepatide pens. Fake pens have in some cases contained insulin.
The right question for a prescription medicine isn't which option is cheapest. It's whether your supply is genuine, your prescriber is qualified, and your ongoing clinical oversight is real. A Mounjaro price reduction from an unverifiable seller is a red flag, not a deal. You can check whether any online pharmacy is legitimately registered on the GPhC register before ordering, it takes about thirty seconds and it matters. Suspected counterfeit sellers can be reported at the MHRA's Yellow Card scheme.
For a fuller breakdown of how private Mounjaro pricing varies across the market, including where to find the cheapest Mounjaro bundles from verified, regulated providers, our cost guide covers the detail. When you're ready to be assessed for suitability, speak to our prescribers through a free consultation, same-day review, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.